Ashley Otter

UK Health Security Agency - Rare & Imported Pathogens Laboratory

SCHOLARLY PAPERS

11

DOWNLOADS
Rank 34,209

SSRN RANKINGS

Top 34,209

in Total Papers Downloads

3,068

TOTAL CITATIONS

6

Scholarly Papers (11)

1.

BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant

Number of pages: 24 Posted: 31 Mar 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Immunology and Immunotherapy, Quinton and Harborne PCN, University of Birmingham - Institute of Immunology and Immunotherapy, Deparment of Buisness Energy and Industrial Strategy - Vaccine Taskforce, Public Health England, Public Health England - Immunisation and Countermeasures Division, Public Health England - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Public Health England, UK Health Security Agency - Rare & Imported Pathogens Laboratory, Government of the United Kingdom - National Infection Service, Government of the United Kingdom - National Infection Service, Public Health England - National Infection Service, Oxford Immunotec LTD, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 1,271 (33,655)

Abstract:

Loading...

Vaccination. SARS-CoV-2. COVID. Immunosenescence. Antibody. T-cell. Variant. Neutralisation. Ageing. Immunisation

2.

Antibody Responses After First and Second COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukaemia

Number of pages: 23 Posted: 25 May 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Applied Health Research, UK Health Security Agency - Rare & Imported Pathogens Laboratory, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Immunology and Immunotherapy, Leeds Teaching Hospitals NHS Trust - St. James’s University Hospital, University Hospitals Birmingham - Queen Elizabeth Hospital, University Hospitals Birmingham - Birmingham Heartlands Hospital, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 1,075 (42,946)
Citation 6

Abstract:

Loading...

Vaccination; CLL; Leukaemia; SARS-CoV-2; COVID; Antibody

3.

Impaired Neutralisation of SARS-CoV-2 Delta Variant in Vaccinated Patients With B Cell Chronic Lymphocytic Leukaemia

Number of pages: 26 Posted: 12 Oct 2021
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Glasgow, University of Glasgow - Centre for Virus Research (CVR), University of Glasgow, University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, UK Health Security Agency - Rare & Imported Pathogens Laboratory, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Cancer and Genomic Sciences, Government of the United Kingdom - Royal Wolverhampton NHS Trust, Barking, Havering and Redbridge University Hospitals NHS Trust - Sandwell and West Birmingham Hospitals NHS Trust, Herefordshire and Worcestershire Health and Care NHS Trust, Government of the United Kingdom - University Hospitals Birmingham, University Hospitals Birmingham - Birmingham Heartlands Hospital and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 179 (347,919)

Abstract:

Loading...

CLL, COVID-19, SARS-CoV-2, Vaccination

4.

Antibody Correlates of Protection Against Delta Infection after Vaccination: A Nested Case-Control within the UK-Based Siren Study

Number of pages: 23 Posted: 18 Apr 2023
Public Health England Colindale, UK Health Security Agency, The Francis Crick Institute, UK Health Security Agency - Rare & Imported Pathogens Laboratory, Public Health England Colindale, The Francis Crick Institute, Public Health England Colindale, UK Health Security Agency, UK Health Security Agency - Rare & Imported Pathogens Laboratory, UK Health Security Agency - Rare & Imported Pathogens Laboratory, UK Health Security Agency, UK Health Security Agency, Francis Crick Institute - Cell Biology of Infection Laboratory and Public Health England Colindale
Downloads 174 (353,155)

Abstract:

Loading...

SARS-CoV-2, Neutralising antibodies, SARS-CoV-2 serology, Immunity

5.

Impact of COVID-19 Vaccination Program on Seroprevalence in Blood Donors in England, 2021

Number of pages: 12 Posted: 30 Mar 2021
Government of the United Kingdom - Public Health England Colindale, Government of the United Kingdom - Public Health England, Public Health England, UK Health Security Agency - Rare & Imported Pathogens Laboratory, UK Health Security Agency, Public Health England, Manchester Royal Infirmary, Government of the United Kingdom - Immunisation and Countermeasures Division, Government of the United Kingdom - Immunisation and Countermeasures Division, Public Health England, Government of the United Kingdom - Immunisation and Countermeasures Division, Government of the United Kingdom - Immunisation and Countermeasures Division, Government of the United Kingdom - Immunisation and Countermeasures Division, Government of the United Kingdom - Public Health England, Public Health England - Immunisation, Hepatitis, and Blood Safety Department, Public Health England and Public Health England - Immunisation and Countermeasures Division
Downloads 166 (369,819)

Abstract:

Loading...

COVID-19, blood donor, serological survey

6.

Immunogenicity of MVA-BN Vaccine Deployed as Mpox Prophylaxis: A Prospective Cohort Study and Analysis of Transcriptomic Predictors of Response

Number of pages: 32 Posted: 16 Sep 2024
University of Oxford, University of Oxford, University of Oxford, UK Health Security Agency - Rare & Imported Pathogens Laboratory, University of Oxford, University of Oxford, University of Oxford, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Uganda Research Unit, University of Oxford, University of Oxford, University of Oxford, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), UK Health Security Agency, Government of the United Kingdom - Oxford University Hospitals NHS Foundation Trust, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, University of Oxford - The Jenner Institute, University of Oxford - Peter Medawar Building for Pathogen Research, UK Health Security Agency - Rare & Imported Pathogens Laboratory, University of Bristol, UK Health Security Agency, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, University of Oxford - The Jenner Institute and University of Oxford
Downloads 122 (471,674)

Abstract:

Loading...

mpox, Vaccine, MVA-BN, Transcriptomics, serology, T cell

7.

Speaking the Same Language: Use of the 1 st WHO International SARS-CoV-2 Immunoglobulin Standard to Achieve Comparability Between Commercial SARS-CoV-2 Binding Antibody Assay Readouts

Number of pages: 27 Posted: 20 Dec 2022
UK Health Security Agency - Rare & Imported Pathogens Laboratory, Government of the United Kingdom - The Medicines and Healthcare products Regulatory Agency, UK Health Security Agency - Rare & Imported Pathogens Laboratory, Government of the United Kingdom - Vaccines (Research and Development), Government of the United Kingdom - The Medicines and Healthcare products Regulatory Agency, UK Health Security Agency - Rare & Imported Pathogens Laboratory, World Health Organization (WHO) - Health Emergency Programme, Government of the United Kingdom - The Medicines and Healthcare products Regulatory Agency, UK Health Security Agency - Rare & Imported Pathogens Laboratory and Independent
Downloads 67 (687,320)

Abstract:

Loading...

SARS-CoV-2SerologyStandardisationAntibody measurement

8.

Large Clones of Pre-Existing T Cells Drive Early Immunity Against SARS-COV-2 and LCMV Infection

Number of pages: 45 Posted: 15 Feb 2023
University College London - Division of Infection and Immunity, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University College London - UCL Genetics Institute, Weizmann Institute of Science - Department of Systems Immunology, University College London - Division of Infection and Immunity, University College London - Division of Infection and Immunity, University College London - Division of Infection and Immunity, University College London - Division of Infection and Immunity, University College London - Division of Infection and Immunity, University College London - Division of Infection and Immunity, University College London - Division of Infection and Immunity, University College London - Division of Infection and Immunity, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University College London - UCL Genetics Institute, Weizmann Institute of Science - Department of Systems Immunology, Weizmann Institute of Science - Department of Systems Immunology, Queen Mary University of London - Blizard Institute, Queen Mary University of London - Blizard Institute, Queen Mary University of London - Blizard Institute, UK Health Security Agency, UK Health Security Agency - Rare & Imported Pathogens Laboratory, Imperial College London - Department of Immunology and Inflammation, Imperial College London - Department of Infectious Disease, University College London - Division of Infection and Immunity, Queen Mary University of London - Blizard Institute, University College London - Institute of Cardiovascular Science, University College London - Institute of Cardiovascular Science, University College London - Institute of Cardiovascular Science, Independent, University College London - Division of Infection and Immunity and University College London - Division of Infection and Immunity
Downloads 14 (1,138,803)

Abstract:

Loading...

SARS-CoV-2, T cell receptor, naive repertoire, LCMV

9.

Differential Antibody Dynamics to Multiple Mpox Antigens Following Two Doses of Mva-Bn (Imvanex) in a Longitudinal Cohort

17TH VACCINE CONGRESS:P2.100
Posted: 28 Sep 2023
Bethany Hicks, Scott Jones, Cathy Rowe and Ashley Otter
UK Health Security Agency, UK Health Security Agency, UK Health Security Agency - Rare & Imported Pathogens Laboratory and UK Health Security Agency - Rare & Imported Pathogens Laboratory

Abstract:

Loading...

10.

Understanding the Impact of Primary Sars-Cov-2 Infection Prior to Vaccination

17TH VACCINE CONGRESS:O1.4
Posted: 28 Sep 2023
UK Health Security Agency - Rare & Imported Pathogens Laboratory, UK Health Security Agency - Rare & Imported Pathogens Laboratory, UK Health Security Agency, UK Health Security Agency, Public Health England Colindale, UK Health Security Agency, UK Health Security Agency, UK Health Security Agency, UK Health Security Agency, UK Health Security Agency - Rare & Imported Pathogens Laboratory, UK Health Security Agency and Public Health England Colindale

Abstract:

Loading...

11.

Analogous Humoral Antigen Recognition between Smallpox-Vaccinated and Mpox-Infected Individuals

17TH VACCINE CONGRESS:O12.2
Posted: 28 Sep 2023
UK Health Security Agency - Rare & Imported Pathogens Laboratory, UK Health Security Agency, UK Health Security Agency, UK Health Security Agency, UK Health Security Agency, UK Health Security Agency, UK Health Security Agency, UK Health Security Agency, UK Health Security Agency, UK Health Security Agency - Rare & Imported Pathogens Laboratory and UK Health Security Agency

Abstract:

Loading...